NEW YORK (GenomeWeb News) — CXR Biosciences has licensed Rosetta Biosoftware’s Resolver system, the companies said today.
 
CXR, a Dundee, Scotland-based drug developer, said it will use the software to determine the toxicological profiles of early-stage compounds in drug -toxicity studies.
 
Financial terms of the deal were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.